Ticker Symbol: SAGE
Sage Therapeutics Inc
$41.77 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001597553
Company Profile
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The Company is pursuing new pathways with the goal of improving brain health, and its depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Its mission is to make medicines that matter so people can get better, sooner.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 215 1st St
Website: www.sagerx.com
CEO: Jeffrey Jonas
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $19.57
Change:
$0.61
(
3.22%)
Days Range: $18.98 - $19.62
Beta: 0.71
52wk. High: $59.99
52wk. Low: $16.52
Ytd. Change -45.45%
50 Day Moving Average: $20.27
200 Day Moving Average: $37.06
Shares Outstanding: 59883943
Valuation
Market Cap: 117.3B
PE Ratio: -1.97
EPS (TTM): -9.93
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A